BUENA, N.J.--(BUSINESS WIRE)--IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based pharmaceutical company, today announced that Jenniffer Collins has been appointed Chief Financial Officer of IGI Laboratories Inc. effective July 21, 2011. Charles Moore, President and CEO, commented, “We are pleased to welcome Jenniffer to the IGI team. She has a strong financial background and will play an integral role in moving the company forward.”
